• Activity INFORMATION

  Overview

  This session is part of the General Pain Specialty Series, which explores overall pain management considerations, best practices, and pain conditions. This module seeks to summarize the best practices in pain management regarding patient education, treatment selection, and adherence and diversion monitoring. This session will also review appropriate, succinct, and comprehensive patient education on naloxone, along with DEA “Red Flags” for prescribers and dispensers, with an emphasis on how to respectfully proceed when misuse, abuse, or diversion is suspected.
  

  Handouts

  • Slide Document :   22158H08_2pp.pdf Download

  • Slide Document :   22158H08_6pp.pdf Download

  Financial Support By

  PharmCon

• Learning OBJECTIVES

  Pharmacist

  Recall the "DEA Red Flags" for prescribers and dispensers, and explain how to respectfully proceed when misuse, abuse, or diversion is suspected and/or confirmed

  Recognize the best practices in pain management in regards to patient education, treatment selection, and adherence/diversion monitoring

  Identify appropriate, succinct, and comprehensive patient education on naloxone

• Activity ACCREDITATION

  Activity Type

  Knowledge

  CE Broker

  20-918917

  Universal Activity Number

  Pharmacist 0798-0000-22-158-H08-P
  

  PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

  PharmCon is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

  In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.

• Activity INSTRUCTION

  Faculty

  Mark  Garofoli, PharmD, MBA, BCGP, CPE, CTTS Assistant Professor, West Virginia University School of Pharmacy

This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).